Ann: Headline Clinical Trial Results , page-14

The market has spoken. For us LT holders we are just going to have to suck it up.

I don't see that much downside to the announcement that would have me cutting my losses like a lot of folk. But there are plenty who beg to differ.

The announcement could have been written differently, but it does give all the information. Is the hard fact that we as LT holders need to face is that doing nothing (or the placebo) provides 20% improvement for 30% of cases "not statistically different" than XToll at only 42%? Is it a very high placebo result or a very low XToll result?

Lastly, why did all these highly credentialed individuals in the pharmaceutical industry get on board with CBio & XToll? It would be good to know their reaction to the results.